PROVECTUS BIOPHARMACEUTICALS, INC. Loss Contingency, Receivable
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) had Loss Contingency, Receivable of $134.75 thousand as of 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency › Loss Contingency, Related Receivable
us-gaap:LossContingencyReceivable · last filed 2019-03-07
- 2018-12-31: Loss Contingency, Receivable $134.75K.
- 2017-12-31: Loss Contingency, Receivable $665.68K.
- 2017-07-25: Loss Contingency, Receivable $6.03M.
- 2016-12-31: Loss Contingency, Receivable $1.32M.
| Period end | Loss Contingency, Receivable |
|---|---|
| 2018-12-31 | $134.75K 10-K · filed 2019-03-07 |
| 2017-12-31 | $665.68K 10-K · filed 2019-03-07 |
| 2017-07-25 | $6.03M 10-K · filed 2018-03-23 |
| 2016-12-31 | $1.32M 10-K · filed 2018-03-23 |
| 2016-12-27 | $2.24M 10-Q · filed 2017-05-10 |
| 2015-12-31 | $2.51M 10-K · filed 2017-03-31 |
| 2014-06-06 | $2.24M 10-K · filed 2018-03-23 |